Navigation Links
MedQuist Names Dominick J. Golio as Chief Financial Officer
Date:4/15/2009

MOUNT LAUREL, N.J., April 15 /PRNewswire-FirstCall/ -- MedQuist Inc. (Nasdaq: MEDQ) today announced it has named Dominick J. Golio as its new Chief Financial Officer. He joined MedQuist on April 13, 2009.

In his role as MedQuist's new CFO, Golio is responsible for directing all financial operations and controls, in addition to financial planning, treasury, financial analysis, investor relations, tax, and financial reporting. "Dominick's broad experience as a Chief Financial Officer will contribute significantly to the overall strategy of the company," said Peter Masanotti, President and CEO. "He has a successful track record in developing high performance teams and brings an exemplary combination of business judgment, professional skills and integrity to MedQuist."

Golio, 63, was most recently the North America Chief Financial Officer for D & M Holdings NA, a Bain Capital Holdings Portfolio Company. Prior to joining D & M Holdings, Golio was Senior Vice President/CFO at Belco Oil & Gas Corporation, an energy company previously listed on the New York Stock Exchange. He also held CFO positions at Millmaster Onyx Group, AEG Corporation NA, and Case Pomeroy & Company.

Golio holds a B.A. and Master's degree in Business Administration from Pace University and is a Certified Public Accountant.

MedQuist is a leading provider of medical transcription services, and a leader in technology-enabled clinical documentation workflow. MedQuist's enterprise solutions -- including mobile voice capture devices, speech recognition, Web-based workflow platforms, and a global network of medical editors -- help healthcare facilities improve patient care, increase physician satisfaction, and lower operational costs. For more information, please v
'/>"/>

SOURCE MedQuist Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. MedQuist Re-launches New, Improved Web Site
2. MedQuist Updates Status of Outstanding SEC Filings
3. MedQuist and MedAssets Sign Multi-Year Contract for Clinical Documentation Workflow Solutions
4. MedQuist Evaluating Whether a Sale of the Company is in the Best Interests of the Company and its Shareholders
5. MedQuist Files Preliminary Proxy Statement and Applies for Listing on NASDAQ
6. MedQuist Announces Appointment of Brian ODonoghue and Mark E. Schwarz to its Board of Directors
7. Leading Arizona Radiological Group Selects MedQuist for Speech Recognition Solution
8. MedQuist Announces Entry Into Settlement Term Sheet Resolving South Broward Litigation
9. MedQuist Technology Solutions to Power Documentation Workflow at New England Facility
10. MedQuist to Get New Majority Stakeholder
11. MedQuist Announces Dismissal of South Broward Litigation and Appointment of New Interim President & CEO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... Gwyneth Paltrow, Beyonce and Angelina Jolie are only ... dieters all over the United States, to find the best ... them quickly shed excess fat. And, recent inspiration has come ... all gluten products, eggs and meats for ingredients like goji ... following this type of diet, one must be a celebrity ...
(Date:8/29/2014)... August 29, 2014 Edvance360, a leading ... tools for online teaching, as well as 2011 winner ... or Learning Management System, announced that their CTO, Brian ... in the ALS Ice Bucket Challenge on behalf of ... Sanders, Edvance360 Co-Founder. , “We know that the options ...
(Date:8/29/2014)... NC (PRWEB) August 29, 2014 In ... of physicians retiring, merging or selling their practices. The ... physicians are likely to retire earlier than planned in ... survey, most U.S physicians are concerned about the future ... healthcare market. In general, physicians are cynical and worried ...
(Date:8/29/2014)... 29, 2014 Hope For The Warriors® ... Spouse/Caregiver Scholarships. Scholarships are awarded two times each year ... to spouses of fallen service members. Hope For The ... sense of self, restoring the family unit, and restoring ... , The Spouse/Caregiver Scholarship Program identifies, recognizes, and ...
(Date:8/29/2014)... Cincinnati, OH (PRWEB) August 29, 2014 Today, ... in the country with not only a healthcare network ... , “We started the network a few weeks ... every state,” said Michael Lee of Progene. , The ... get to take care of our customers before and after ...
Breaking Medicine News(10 mins):Health News:Diet Doc Announces Diet Plans that Deliver Fast Weight Loss Results at a Fraction of the Cost of Celebrity Diets 2Health News:Diet Doc Announces Diet Plans that Deliver Fast Weight Loss Results at a Fraction of the Cost of Celebrity Diets 3Health News:Edvance360 Participates In the ALS Ice Bucket Challenge (#ALSicebucketchallenge) 2Health News:Planning for Retiring, Selling, or Closing Down the Practice? Help is at Hand 2Health News:Planning for Retiring, Selling, or Closing Down the Practice? Help is at Hand 3Health News:Planning for Retiring, Selling, or Closing Down the Practice? Help is at Hand 4Health News:Hope For The Warriors Announces Fall 2014 Spouse/Caregiver Scholarship Recipients 2Health News:Hope For The Warriors Announces Fall 2014 Spouse/Caregiver Scholarship Recipients 3Health News:Progene Is Doctor Recommended Nationwide 2Health News:Progene Is Doctor Recommended Nationwide 3
... Ky., Dec. 23 A group representing some of the ... drop language that would require vending companies to disclose the ... the point of sale, Vend Marketing Institute (VMI) Executive Director ... both the House and Senate versions of the healthcare reform ...
... for King Herod Himself , WASHINGTON, Dec. 23 As ... Reid,s health care bill, Family Research Council Action (FRC Action) ... call campaign in six states -- Nebraska, Arkansas, Louisiana, South ... to contact their Senators and tell them "don,t trade the ...
... Female janitors, scientists among those at highest risk, study ... working women in the United States, teachers seem to ... defects, while those who work as janitors, scientists and ... The study looked at nearly 9,000 babies born with ...
... ... conference provides First Responders with professional education and networking opportunity. , ... (PRWEB) December 23, ... Responders with professional education and networking opportunity., , ,Against a background of threats ...
... ... provider, today announced the appointment of a new leader who will help expand its ... ... debate rages on all sides of healthcare reform, one fact remains: the heavy lifting ...
... A McMaster University researcher has found the first evidence ... in car exhaust fumes and industrial air pollution can lead ... Infectious disease specialist Mark Loeb led a research team ... and sulfur dioxide, both found in motor vehicle emissions, and ...
Cached Medicine News:Health News:Vend Marketing Institute Calls on Congress to Modify Calorie Disclosure Requirement: Supports Existing Disclosure Which Is More Complete and Effective 2Health News:Vend Marketing Institute Calls on Congress to Modify Calorie Disclosure Requirement: Supports Existing Disclosure Which Is More Complete and Effective 3Health News:FRC Action Launches Last Minute Phone Call Campaign in Six States 2Health News:Mom's Job Could Boost Baby's Odds for Birth Defect 2Health News:5th Annual Homeland Security Professionals Conference and Exposition in Vegas on October 25-29 2010 2Health News:5th Annual Homeland Security Professionals Conference and Exposition in Vegas on October 25-29 2010 3Health News:New Executive Director to Lead Medical Education to Greater Relevance 2Health News:Air pollution linked to hospitalizations for pneumonia in seniors 2
(Date:8/28/2014)... Aug. 28, 2014 Tianyin Pharmaceutical Co., ... pharmaceutical company that specializes in patented biopharmaceutical, modernized ... pharmaceutical ingredients (API) today updates the timeline for ... (QLF). The Company is scheduled ... for China Food & Drug Administration,s (CFDA) review ...
(Date:8/28/2014)... Aug. 28, 2014  A candidate Ebola vaccine could be given ... and Mali as early as September, ... aimed at preventing the disease that has killed more than 1,400 ... . Human trials of this candidate vaccine, being co-developed ... to be accelerated with funding from an international consortium in response ...
(Date:8/28/2014)... Mass. , Aug. 28, 2014  Seres ... for diseases related to the human microbiome, announced ... Executive Vice President of R&D and Chief Scientific ... Conference on Antimicrobial Agents and Chemotherapy (ICAAC). The ... of SER-109, a novel mixture of bacterial spores ...
Breaking Medicine Technology:TPI Submits Dataset for GMP Inspection at Qionglai Facility (QLF) 2Ebola vaccine trials fast-tracked by international consortium 2Ebola vaccine trials fast-tracked by international consortium 3Ebola vaccine trials fast-tracked by international consortium 4Ebola vaccine trials fast-tracked by international consortium 5Ebola vaccine trials fast-tracked by international consortium 6Ebola vaccine trials fast-tracked by international consortium 7Seres Health to Present Clinical Findings at ICAAC 2014 Conference 2
... NxStage Medical, Inc. (Nasdaq: NXTM ) a leading manufacturer of innovative dialysis products, today announced that it has secured a two-year $15 million revolving line of credit ... ... ... ...
... 11 Watson Pharmaceuticals, Inc. (NYSE: ... Administration (FDA) approval of TRELSTAR® 22.5 mg (triptorelin pamoate ... a proven, simple and effective palliative treatment of advanced ... mg is the first and only six-month intramuscular (IM) ...
Cached Medicine Technology:NxStage(R) Secures $15 Million Revolving Line of Credit 2NxStage(R) Secures $15 Million Revolving Line of Credit 3NxStage(R) Secures $15 Million Revolving Line of Credit 4FDA Approves Watson's TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer 2FDA Approves Watson's TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer 3FDA Approves Watson's TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer 4FDA Approves Watson's TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer 5FDA Approves Watson's TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer 6FDA Approves Watson's TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer 7FDA Approves Watson's TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer 8
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: